InstrumentpanelPortföljerBevakningslistaGemenskapUpptäckSkärm
NOT FOR DISTRIBUTION

Marex Group Limited

NasdaqGS:MRX Aktierapport

Börsvärde: US$5.3b

  • Översikt över företaget
  • Värdering
  • Framtida tillväxt
  • Tidigare resultat
  • Finansiell hälsa
  • Utdelning
  • Förvaltning
  • Ägarskap
  • Övrig information
  • Aktiegemenskap

Marex Group Tidigare resultatutveckling

Tidigare kriterier kontrolleras 5/6

Marex Group har ökat intäkterna med en genomsnittlig årlig takt på 35.3%, medan Capital Markets -branschen såg intäkterna växer på 7% årligen. Intäkterna har varit växande med en genomsnittlig takt på 27.3% per år. Marex Group s avkastning på eget kapital är 20.9% och den har en nettomarginal på 10.8%.

Viktig information

35.35%

Tillväxttakt i vinsten

38.24%

Tillväxttakt för EPS

Capital Markets Tillväxt i branschen10.26%
Intäkternas tillväxttakt27.33%
Avkastning på eget kapital20.92%
Nettomarginal10.77%
Senaste uppdateringen av resultatet30 Jun 2026

Senaste uppdateringar av tidigare prestationer

Recent updates

User avatar
Uppdatering av berättelse • Sep 03

MRX: Acquisition Momentum And Higher Margins Will Support Further Upside

Analysts have raised the Marex Group price target from $72.38 to $79.88, citing updated assumptions for a smaller revenue decline, a slightly higher profit margin, a modestly higher discount rate, and a slightly lower future P/E multiple. What’s in the News for Marex Group Marex Group reported Q2 2026 revenue of US$695.8 million, which was 39% higher year over year and more than 11% above analyst estimates.
User avatar
Uppdatering av berättelse • Aug 20

MRX: Higher Profitability And Volatility-Driven Trading Volumes Will Support Upside

Marex Group's analyst fair value estimate has been revised from $75.00 to $100.00 as analysts factor in slightly higher assumed profit margins and a higher future P/E multiple, despite modestly softer projected revenue growth and a marginally higher discount rate. What’s in the News for Marex Group Marex Group reported Q2 2026 revenue of about US$696 million, up 39% year over year, with growth coming from all four business segments.
Seeking Alpha • Aug 17

Recent Results From Marex Group Impress, But Some Risks Are Rising

Summary Marex Group delivered record H1 2026 revenue and profitability, with adjusted profit before tax of $318.6 million, driving an 18% stock surge on August 12. MRX's rapid acquisition strategy fueled significant YoY segment revenue growth, notably 134% in Market Making and 35% in Agency and Execution. Operational efficiency improved: adjusted profit margin rose 200 bps to 23%, and adjusted ROE reached 37.5%, nearly 700 bps higher YoY. Despite valuation concerns and increased risk from acquisitions and debt, I maintain a Buy rating on MRX given sustained earnings momentum. Read the full article on Seeking Alpha
User avatar
Uppdatering av berättelse • Aug 06

MRX: Rich Earnings Multiple Will Confront Weaker Revenue And Index Exclusion Risk

Analysts have raised their price target for Marex Group from about $37.00 to roughly $44.00, reflecting updated assumptions on fair value, discount rate, revenue growth, profit margin and future P/E. What's in the News Marex Group completed the acquisition of European equity derivatives market maker Webb Traders, which focuses on single stock options for European and US mid and large cap equities.
User avatar
Uppdatering av berättelse • Jul 23

MRX: Bermuda Move And Digital Collateral Shift Will Constrain Upside Potential

Analysts have raised their price target for Marex Group from $59.75 to $72.38, citing updated assumptions around revenue contraction, profit margin, and future P/E that together support a higher fair value estimate. What’s in the News for Marex Group Marex Group is allowing derivatives clients to post USDC stablecoin as initial margin collateral using Coinbase infrastructure, following a December 2025 CFTC no action letter that permits futures commission merchants to accept certain digital assets as margin.
User avatar
Uppdatering av berättelse • Jul 08

MRX: Bermuda Redomiciliation Will Limit Future Upside From Current Levels

Analysts have nudged their price target for Marex Group higher from $57.13 to $59.75, citing updated assumptions that combine slightly softer revenue expectations with a small improvement in projected profit margins and a modestly higher future P/E multiple. What’s in the News for Marex Group Marex Group Limited completed its redomiciliation from England and Wales to Bermuda on July 1, 2026, following shareholder approval on May 21, 2026, and English High Court sanction on June 26, 2026.
User avatar
Uppdatering av berättelse • Jun 22

MRX: Higher Fair Value And Market Volatility Tailwinds Will Support Upside

Analysts have raised their price target for Marex Group from $66.00 to $75.00, citing updated assumptions around revenue trends, a slightly higher discount rate, and modestly adjusted profit margin and P/E expectations. What’s in the News for Marex Group Night Watch Investment Management identified Marex Group plc as its largest holding, highlighting the futures clearing business as critical financial infrastructure with a strong and defensible market position, and pointing to earnings that have grown roughly 7x over the past five years, according to recent commentary from the firm.
User avatar
Uppdatering av berättelse • Jun 05

MRX: Levmet Deal And Bermuda Move Will Support Measured Future Upside

Analysts have maintained their $57.13 price target for Marex Group, reflecting steady assumptions for its discount rate, an expected revenue decline of 7.25%, a profit margin of 20.12% and a future P/E of 11.49x. What's in the News Marex Group agreed to acquire Levmet, a Monaco based liquidity provider focused on base and ferrous metals, energy, and power.
User avatar
Uppdatering av berättelse • May 22

MRX: Q1 2026 Guidance And Dividend Outlook Will Support Measured Upside

Analysts have raised their price target for Marex Group from $55.00 to $57.13, citing updated assumptions on revenue trends, profit margins and future P/E expectations. What's in the News Marex Group plc issued earnings guidance for the first quarter of 2026, with expected revenue in a range of $667 million to $697 million for the period ended March 31, 2026, compared with Q1 2025 revenue of $467 million (Key Developments).
User avatar
Uppdatering av berättelse • May 07

MRX: Higher Margins And Q1 2026 Outlook Will Support Measured Upside

Analysts have lifted Marex Group's price target from $50.29 to $55.00 as they now factor in a higher profit margin of about 20.9% and a lower future P/E of roughly 9.7, despite softer revenue growth assumptions and a slightly higher discount rate. What's in the News Marex Group issued earnings guidance for the first quarter ended March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
User avatar
Uppdatering av berättelse • Apr 22

MRX: Higher Fair Value And Lower Future P/E Will Support Upside

Analysts have lifted their fair value estimate for Marex Group from $61.00 to $66.00, citing updated assumptions for modest positive revenue growth, a slightly higher profit margin, and a lower future P/E of 11.40 compared with the prior 13.35. What's in the News Marex Group issued earnings guidance for the quarter ending March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
User avatar
Uppdatering av berättelse • Apr 07

MRX: Rich Earnings Multiple Will Face Test From Softer Revenue Outlook

Analysts have inched their price targets for Marex Group higher by a few dollars into the mid $40s, reflecting updated views on revenue trends, margins, and a lower forward P/E assumption in recent TD Cowen, Piper Sandler, and Barclays research. Analyst Commentary Recent research reflects a mixed tone, with some optimism on Marex Group's revenue and margin outlook, alongside more cautious views on where the shares should trade relative to sector peers.
User avatar
Uppdatering av berättelse • Mar 24

MRX: Volatility And Trading Volumes Will Test Fairly Priced Shares

Analysts have lifted their average price target on Marex Group by mid single digits. Recent moves include $7 and $5 increases, citing updated assumptions for revenue trends, profit margins, and a lower implied future P/E multiple despite a slightly higher discount rate.
User avatar
Uppdatering av berättelse • Mar 09

MRX: Higher Trading Volumes And Supportive P/E Will Drive Future Upside

Analysts have lifted their average price target on Marex Group to $61, citing updated views on revenue trajectory, profit margins, and a modestly higher future P/E multiple informed by recent Street research revisions from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Bullish analysts are leaning into Marex Group's execution by lifting their individual price targets, which helps explain the higher Street average.
User avatar
Uppdatering av berättelse • Feb 23

MRX: Rising Trading Volumes And Volatility Will Support Earnings Power

Narrative update on Marex Group Analysts have nudged their Marex Group price targets higher by $7 and $5 in recent updates, while one cut a target by $1 to $49. These changes reflect adjusted views on volumes, volatility, and earnings potential rather than a change to our $61 fair value estimate.
User avatar
Uppdatering av berättelse • Feb 07

MRX: Higher Volatility And Volumes Will Support Earnings Power Going Forward

The analyst price target for Marex Group has increased from $56 to $61, with analysts citing updated views on revenue trends, profit margins, and future P/E assumptions reflected in recent research from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Recent research updates show bullish analysts lifting their fair value estimates for Marex Group, with the latest round of work incorporating refreshed views on revenue trends, margin resilience, and P/E assumptions.
User avatar
Uppdatering av berättelse • Jan 23

MRX: US Expansion And Higher Trading Volumes Will Support Future Upside

Analysts have raised their price targets on Marex Group, reflecting a revised fair value estimate from $47.71 to $50.29 as they factor in updated expectations around volumes, revenue trends, margins, and future P/E assumptions following recent sector research. Analyst Commentary Recent research updates on Marex Group show a mix of optimism and caution as analysts refresh their models ahead of upcoming results and sector comparisons.
User avatar
Uppdatering av berättelse • Jan 08

MRX: Rising Trading Activity Will Support Earnings Power Despite Slight Price Trim

Analysts have trimmed their price target on Marex Group to US$49 from US$50, citing refreshed views on sector volumes and volatility while keeping fair value and key valuation inputs broadly unchanged. Analyst Commentary Bullish analysts are treating the lower US$49 price target as a fine tuning rather than a reset, keeping their broader view on Marex Group intact while they refresh assumptions for sector activity.
User avatar
Uppdatering av berättelse • Dec 23

MRX Will Benefit From Expanding US Structured Products And Margin Resilience

Analysts have trimmed their price target on Marex Group by 4 percent to $56.00, citing slightly higher discount rates and weaker revenue growth expectations, partly offset by improved profit margin forecasts and a more attractive forward earnings multiple. What's in the News Marex Group launched a US structured products business targeting RIAs, broker dealers, and private banks.
User avatar
Uppdatering av berättelse • Dec 09

MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits

Narrative Update on Marex Group Price Target Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.
User avatar
Uppdatering av berättelse • Nov 25

MRX: Diversified US Expansion Will Drive Recovery Despite Securities Lawsuit Risk

Analysts have raised their price target for Marex Group from $47.67 to $49.00, citing updated assumptions around profit margins and discount rates, which support a modestly higher valuation. What's in the News Marex Group has launched its structured products business in the United States, led by Scott Kerbel.
User avatar
Uppdatering av berättelse • Nov 06

MRX: Revenue Outlook Will Support Rebound Despite Ongoing Class Action Lawsuits

Analysts have made a minor upward adjustment to the price target for Marex Group, now set at $47.67. This change is based on slight improvements in the revenue growth outlook and a stable discount rate.
User avatar
Uppdatering av berättelse • Oct 23

Analysts Lower Marex Group Price Target Amid Accounting Allegations and Revised Profit Outlook

Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.
User avatar
Uppdatering av berättelse • Oct 08

Digitalization And M&A Will Unlock Global Market Potential

Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections. What's in the News NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).
User avatar
Ny berättelse • Apr 27

Acquisitions Will Fuel APAC And Middle East Expansion

Strong market share gains and acquisition integration are driving revenue growth and expanding product offerings and geographic reach.

Fördelning av intäkter och kostnader

Hur Marex Group tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.


Resultat- och intäktshistorik

NasdaqGS:MRX Intäkter, kostnader och resultat (USD Millions )
DatumIntäkterIntäkterG+A KostnaderFoU-kostnader
30 Jun 263,4893761,4850
31 Mar 263,2663341,3860
31 Dec 252,8702941,2500
30 Sep 252,6682661,1560
30 Jun 252,6082511,1050
31 Mar 252,5302341,0520
31 Dec 242,3572059900
30 Sep 242,1421899390
30 Jun 241,8831341,2830
31 Mar 241,8491401,0280
31 Dec 231,8821287990
30 Sep 231,0921407370
30 Jun 231,8181394510
31 Mar 231,5701154510
01 Jan 231,010924590
01 Jan 22825573710
31 Dec 20758442770
31 Dec 19549362120
31 Dec 183841000
31 Dec 173181800
31 Dec 163282000
31 Dec 153461800

Kvalitetsintäkter: MRX har inkomster av hög kvalitet.

Växande vinstmarginal: MRX s nuvarande netto vinstmarginaler (10.8%) är högre än förra året (9.6%).


Fritt kassaflöde vs resultatanalys


Analys av tidigare vinsttillväxt

Resultatutveckling: MRX s intäkter har ökat markant med 35.3% per år under de senaste 5 åren.

Accelererande tillväxt: MRX s intäktstillväxt under det senaste året ( 49.7% ) överstiger sitt 5-åriga genomsnitt ( 35.3% per år).

Resultat vs industri: MRX vinsttillväxt under det senaste året ( 49.7% ) översteg Capital Markets branschen 32.9%.


Avkastning på eget kapital

Hög ROE: Medan MRX s avkastning på eget kapital ( 20.92% ) är hög, är detta mått skevt på grund av deras höga skuldnivå.


Avkastning på tillgångar


Avkastning på sysselsatt kapital


Upptäck starka bolag som tidigare presterat bra

7D

1Y

7D

1Y

7D

1Y

Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2026/09/13 03:02
Aktiekurs vid dagens slut2026/09/11 00:00
Intäkter2026/06/30
Årlig intjäning2025/12/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
  • SEC Form 10-K
  • SEC Form 10-Q
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
  • Rapporter från analytiker
  • Blue Matrix
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
  • ICE Marknadsdata
  • SEC Form S-1
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
  • SEC Formulär 4
  • SEC Formulär 13D
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
  • SEC Form 10-K
  • SEC Form DEF 14A
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden
  • SEC Formulär 8-K

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om analysmodellen som används för att skapa den här rapporten finns på vår Github-sida, vi har också guider om hur du använder våra rapporter och handledningar på Youtube.

Lär dig mer om det som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Marex Group Limited bevakas av 11 analytiker. 7 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Benjamin BudishBarclays
Christopher AllenCitigroup Inc
Alexander BlosteinGoldman Sachs

Ta bättre investeringsbeslut var som helst

Skanna för att ladda ner
Öppna App StoreÖppna Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Visa datakällor
Marknader
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investeringsidéer
  • Undervärderade bolag
  • Starka utdelningar
  • Insiderköp
  • Kärnenergi
  • Autonoma fordon
  • Artificiell intelligens
  • Krypto och blockkedja
  • Cybersäkerhet
  • Fler idéer
Lager Gemenskaperna
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Funktioner och verktyg
  • Portföljspårning
  • Aktieskärm och varningar
  • Berättelser & rättvisa värden
  • Kalkylator för utdelning
Nyheter & Upptäckter
  • Senaste lagernyheter
  • Global Market Insights
  • Foxhole-forumet
  • Investeringsidéer
  • Gemenskapens berättelser
  • Vad är nytt
Simply Wall St
  • Planer och priser
  • Annonsering
  • Om oss
  • Kontakta oss
  • Karriär
  • Hjälpcenter
  • Lär dig investera i aktier
  • Affiliate-program
  • Affärer & företag
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Villkor och anvisningar
  • Integritetspolicy
  • AI-villkor
  • Guide för finansiella tjänster